Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European OTC Market Conference In Brief

This article was originally published in The Tan Sheet

Executive Summary

Countries expand nonprescription sales: Italy and Hungary ease regulations for sales of nonprescription drugs. Drug companies and stores in Italy now can price nonprescription drugs as they wish as long as the amounts do not exceed prices set in December 2006 and are visible at points of sale, Guido Rasi, director general of the Italian Medicines Agency, said at the Association of the European Self-Medication Industry's (AESGP) Nov. 5 conference in Paris. Rasi added that retail prices also can be discounted. Through October 2008 in Hungary, 701 licensed non-pharmacy outlets were selling nonprescription products, including analgesics and vitamins, said Zsuzanna Szepezdi, director general of the country's National Institute of Pharmacy. She explained that Hungary eased nonprescription sales regulations in early 2007 so that some products can be sold outside the pharmacy if they are stored in closed cupboards and information about the products is available via electronic information systems

You may also be interested in...



U.K. Regulatory Agency's Move Draws Industry Attention

Drug industry stakeholders in European Union markets will watch carefully in October when the U.K.'s regulator moves to a new office, with OTC marketers having reason to pay particularly close attention

U.K. Regulatory Agency's Move Draws Industry Attention

Drug industry stakeholders in European Union markets will watch carefully in October when the U.K.'s regulator moves to a new office, with OTC marketers having reason to pay particularly close attention

U.K. Regulatory Agency's Move Draws Industry Attention

Drug industry stakeholders in European Union markets will watch carefully in October when the U.K.'s regulator moves to a new office, with OTC marketers having reason to pay particularly close attention

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel